Improved detection of nonmuscle invasive urothelial carcinoma of the bladder using pirarubicin endoscopy: a prospective, single-center preliminary study.

Abstract

BACKGROUND AND PURPOSE:

Fluorescence cystoscopy (FC) with intravesical instillation of a photosensitizing agent has emerged as an adjunctive and safe diagnostic tool with high sensitivity and reasonable specificity; however, it has not been widely accepted, because it is time-consuming and expensive. The aim of the present study was to determine whether the use of the fluorescent dye pirarubicin [(2"R)-4'-O-tetrahydropyranyl doxorubicin] (THP) in endoscopy can improve detection of nonmuscle invasive urothelial carcinoma of the bladder.

PATIENTS AND METHODS:

Forty-eight patients with known or suspected bladder urothelial carcinoma were enrolled in this prospective study between January 2008 and April 2009. The Storz D-light system was used to detect fluorescence 15 minutes after intravesical instillation with 30 mg THP. Endoscopic findings, histopathologic evaluation of biopsy lesions, and adverse effects of THP were recorded.

RESULTS:

After THP uptake, the lesions appear bright orange under white light, and produce bright red fluorescence under blue light. Among 238 biopsies evaluated (84 malignant, 20 dysplasia, and 134 benign), sensitivity of overall tumors, carcinoma in situ (CIS), and dysplasia detection using FC was 96% (81/84), 100% (6/6), and 90% (18/20), respectively. The specificity of FC was 74.7% (115/154), and its false-positive rate was 32.5% (39/120). No significant systemic side effects or allergic reactions were observed other than a few cases of mild cystitis.

CONCLUSION:

THP endoscopy may improve the detection of nonmuscle invasive urothelial carcinoma of the bladder, especially CIS and flat lesions. Results indicate that THP is a promising fluorescent dye for diagnosis and follow-up of nonmuscle invasive bladder carcinoma. Moreover, it is inexpensive, easily available, simple to administer, and is associated with few side effects.

• Authors: Jinli Han, Tianxin Lin, Kewei Xu, Chun Jiang, Hai Huang, Xinbao Yin, Wenlian Xie, Yousheng Yao, Caixia Zhang, Jian Huang
• Journal: Journal of endourology (J Endourol) Vol. 24 Issue 11 Pg. 1801-6 (Nov 2010) ISSN: 1557-900X [Electronic] United States
• PMID: 20932082 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Doxorubicin
• pirarubicin

Topics

• Adult
• Aged
• Aged, 80 and over
• Biopsy
• Carcinoma, Transitional Cell (diagnosis, pathology)
• Cystoscopy (methods)
• Doxorubicin (analogs & derivatives)
• Fluorescence
• Humans
• Middle Aged
• Muscles (pathology)
• Neoplasm Invasiveness
• Neoplasm Staging
• Prospective Studies
• Urinary Bladder Neoplasms (diagnosis, pathology)